Core Viewpoint - The lawsuit against James Hardie Industries plc alleges that the company misled investors about the sustainability of growth in its North America Fiber Cement segment, leading to a significant stock price drop of 34% when the truth was revealed [2][5]. Allegations and Financial Impact - The lawsuit claims that James Hardie falsely stated that customer inventory levels were "normal," while in reality, customers were experiencing aggressive inventory destocking starting in April and May 2025 [5]. - Sales were allegedly inflated due to "inventory loading" by channel partners, which misrepresented the stability of customer demand and inventory levels [5]. - Following the disclosure of a 12% decline in North America Fiber Cement sales, the stock price dropped approximately $9.79 per share [5]. Legal Issues - The key legal issues include whether James Hardie misrepresented the stability of customer demand and inventory levels, and whether the failure to disclose the alleged sales practices violated federal securities laws [5]. - The lawsuit covers investors who purchased James Hardie securities between May 20, 2025, and August 18, 2025, and examines the sudden CFO replacement announced on November 17, 2025, as a potential indicator of the alleged issues [5]. Next Steps for Investors - Hagens Berman is advising investors who purchased JHX shares during the class period and suffered significant losses to contact the firm [6]. - The deadline for investors to move the court for appointment as lead plaintiff is December 23, 2025 [1][7].
JHX LAWSUIT DEADLINE: Hagens Berman Urges James Hardie Investors to Act by Dec. 23 in Suit Over 34% Plunge Due to Inventory Destocking